SCHEMBL28653283

SCHEMBL28653283

CC1CC(CN2CCN(C)CC2)CN(c2ccc(C(F)(F)F)c3ncccc23)C1.CC1CC(CO)CN(c2ccc(C(F)(F)F)c3ncccc23)C1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TLR7 Q9NYK1 1/20 0.41
NCF1 P14598 1/20 0.40
TLR8 Q9NR97 1/20 0.35
DRD2 P14416 2/20 0.35
DRD3 P35462 2/20 0.35
METAP2 P50579 1/20 0.34
SSTR4 P31391 4/20 0.33
GAA P10253 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
MEN1 O00255 1/20 0.33
USP2 O75604 1/20 0.33
LMNA P02545 1/20 0.33
CASP1 P29466 1/20 0.33
CASP7 P55210 1/20 0.33
KMT2A Q03164 1/20 0.33
ACHE P22303 1/20 0.33
KDM4E B2RXH2 1/20 0.33
RAD52 P43351 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
MAPT P10636 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18980128 0.95 TLR7 (0.42) TLR7NCF1TLR8DRD2DRD3
SCHEMBL29722232 0.95 TLR7 (0.42) TLR7NCF1TLR8DRD2DRD3
SCHEMBL18980466 0.95 TLR7 (0.42) TLR7NCF1TLR8DRD2DRD3
SCHEMBL18980130 0.95 TLR7 (0.42) TLR7NCF1TLR8DRD2DRD3
SCHEMBL18980127 0.95 TLR7 (0.42) TLR7NCF1TLR8DRD2DRD3
SCHEMBL23894300 0.95 TLR7 (0.42) TLR7NCF1TLR8DRD2DRD3
SCHEMBL18980465 0.95 TLR7 (0.42) TLR7NCF1TLR8DRD2DRD3
SCHEMBL18980695 0.90 TLR7 (0.48) TLR7NCF1TLR8SSTR4MEN1
SCHEMBL18980767 0.80 TLR7 (0.40) TLR7NCF1TLR8USP2KDM4E
SCHEMBL18980379 0.80 TLR7 (0.40) TLR7NCF1TLR8USP2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108699032-B Polycyclic TLR7/8 antagonists and their use in the treatment of immune disorders 默克专利有限公司 2022-07-22 CN disclosed
CN-113603675-A Polycyclic TLR7/8 antagonists and their use in the treatment of immune disorders 默克专利有限公司 2021-11-05 CN disclosed